Literature DB >> 11953331

Influence of treatment on morphological features of mucosal inflammation.

K Geboes1, I Dalle.   

Abstract

Microscopic analysis of endoscopically obtained tissue samples is important for the diagnosis of several gastrointestinal disorders such as gastritis and chronic inflammatory bowel disease (IBD). Histologically disease activity is based on the presence of neutrophilic polymorphonuclear leucocytes in conjunction with epithelial damage. Effective eradication treatment for Helicobacter pylori related gastritis reduces active inflammation rapidly whereas chronic inflammation decreases only slowly. Similar findings have been obtained for IBD. A literature review of clinical drug trials in IBD and the effect of various drugs on the microscopic features of Crohn's disease and immunohistochemistry for different markers was performed. Diagnostic microscopic features and the features characteristic for disease activity vary with time and treatment. The more recently developed drugs used for Crohn's disease can induce mucosal healing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953331      PMCID: PMC1867680          DOI: 10.1136/gut.50.suppl_3.iii37

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  69 in total

1.  Biopsy diagnosis of colitis: possibilities and pitfalls.

Authors:  P Tsang; H Rotterdam
Journal:  Am J Surg Pathol       Date:  1999-04       Impact factor: 6.394

Review 2.  Grading and scoring in histopathology.

Authors:  S S Cross
Journal:  Histopathology       Date:  1998-08       Impact factor: 5.087

3.  Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

Authors:  F J Baert; G R D'Haens; M Peeters; M I Hiele; T F Schaible; D Shealy; K Geboes; P J Rutgeerts
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

4.  Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease?

Authors:  K Geboes; N Ectors; G D'Haens; P Rutgeerts
Journal:  Am J Gastroenterol       Date:  1998-02       Impact factor: 10.864

5.  Does quantitative histology of rectal biopsy improve the differential diagnosis of Crohn's disease and ulcerative colitis in adults?

Authors:  P Schmitz-Moormann; G W Himmelmann
Journal:  Pathol Res Pract       Date:  1988-08       Impact factor: 3.250

Review 6.  Endoscopy in inflammatory bowel disease: indications and differential diagnosis.

Authors:  J D Waye
Journal:  Med Clin North Am       Date:  1990-01       Impact factor: 5.456

7.  Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

Authors:  J Y Mary; R Modigliani
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

8.  Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time.

Authors:  C G Kleer; H D Appelman
Journal:  Am J Surg Pathol       Date:  1998-08       Impact factor: 6.394

9.  Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation.

Authors:  G Olaison; R Sjödahl; C Tagesson
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

10.  Morphologic and functional effects of bile salt on the porcine colon during injury and repair.

Authors:  C K Henrikson; R A Argenzio; J A Liacos; J Khosla
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

View more
  35 in total

Review 1.  Biopsy assessment of drug efficacy in the gastrointestinal tract.

Authors:  Marjorie M Walker
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

Review 2.  Indeterminate colitis.

Authors:  M Guindi; R H Riddell
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

3.  Synbiotic therapy for ulcerative colitis.

Authors:  J E D Mawdsley; J Lindsay; D Rampton
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

4.  Value of MR colonography for assessment of inflammatory bowel disease? Believe what you see--see what you believe.

Authors:  C Gasche; K Turetschek
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

5.  Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn's disease.

Authors:  B H Drews; T F E Barth; M M Hänle; A S Akinli; R A Mason; R Muche; R Thiel; S Pauls; J Klaus; G von Boyen; W Kratzer
Journal:  Eur Radiol       Date:  2009-01-30       Impact factor: 5.315

Review 6.  Clinical implications of mucosal healing for the management of IBD.

Authors:  Guillaume Pineton de Chambrun; Laurent Peyrin-Biroulet; Marc Lémann; Jean-Frédéric Colombel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-12-01       Impact factor: 46.802

Review 7.  Histological healing in inflammatory bowel disease: a still unfulfilled promise.

Authors:  Vincenzo Villanacci; Elisabetta Antonelli; Karel Geboes; Giovanni Casella; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

8.  Glutathione peroxidase-2 and selenium decreased inflammation and tumors in a mouse model of inflammation-associated carcinogenesis whereas sulforaphane effects differed with selenium supply.

Authors:  Susanne Krehl; Maria Loewinger; Simone Florian; Anna P Kipp; Antje Banning; Ludger A Wessjohann; Martin N Brauer; Renato Iori; Robert S Esworthy; Fong-Fong Chu; Regina Brigelius-Flohé
Journal:  Carcinogenesis       Date:  2011-12-17       Impact factor: 4.944

Review 9.  Mucosal healing and deep remission: what does it mean?

Authors:  Gerhard Rogler; Stephan Vavricka; Alain Schoepfer; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

10.  Immunomodulation does not alter histology in resected Crohn's disease.

Authors:  F A Frizelle; A Ing; R B Gearry; M Whitehead; I G Faragher; B Dobbs
Journal:  Tech Coloproctol       Date:  2009-09-23       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.